Applicability of biosensor technologies in the detection of Coxiella burnetii infection in clinical samples

Petia Genova-Kalou,Georgi Dyankov,Stefka Krumova,Konstantin Simeonov,Trifon Valkov,Magdalena Baymakova,Ilia Tsachev,Pierre-Edouard Fournier
DOI: https://doi.org/10.1080/13102818.2024.2350163
2024-05-08
Biotechnology & Biotechnological Equipment
Abstract:Q fever is a zooantroponoze distributed worldwide; it is caused by obligate intracellular bacterium Coxiella burnetii . Q fever is considered challenging for diagnosis and treatment. Clinical manifestations can vary among patients, which makes differential diagnosis difficult. In addition, in animals, the infection often remains latent, thus, creating a risk of uncontrolled dissemination and transmission to humans. Hence, the need for rapid and accurate identification of the pathogen to take timely and adequate therapeutic and prophylactic measures, including on-site testing. Current strategies for the detection of C. burnetii are molecular assays, e.g. polymerase chain reaction (PCR) or next-generation sequencing (NGS), and traditional serological tests. The conventional pathogen detection methods have serious limitations that make them not suitable for on-site analysis, as it requires level three biosafety laboratory conditions for cultivation in eukaryotic cell culture and poses significant health risks. In this review, we highlight the problems related to the application of biosensors in the detection of C. burnetii infection and their place among the standard diagnostic methods, given the potential of biosensors to provide rapid and quantitative diagnosis. We consider the applicability of surface plasmon resonance (SPR)-based biosensors for C. burnetii detection. The elaboration of an SPR biochip with an immobilized structural C. burnetii protein as a recognition molecule is described. The SPR assay is based on the binding reaction 'infectious structural protein – anti- C. burnetii antibodies'. We discuss our preliminary results addressing their application in C. burnetii detection.
biotechnology & applied microbiology
What problem does this paper attempt to address?
The paper primarily explores the issue of detecting Q fever infections caused by Coxiella burnetii in clinical samples using biosensor technology. Q fever is a globally distributed zoonotic disease caused by the bacterium Coxiella burnetii. This pathogen can be transmitted to humans through inhalation of contaminated aerosols, consumption of contaminated dairy products, or tick bites. The paper points out that diagnosing Q fever is challenging due to its diverse clinical symptoms, which are similar to many other febrile illnesses, making differential diagnosis difficult. Additionally, in animals, the infection often remains latent, increasing the difficulty of disease control and prevention. Therefore, rapid and accurate identification of the pathogen is crucial for timely treatment and preventive measures. Current methods for detecting Coxiella burnetii include molecular biology techniques (such as Polymerase Chain Reaction (PCR) and Next-Generation Sequencing (NGS)) and traditional serological tests. However, these methods have some limitations, such as requiring high-level biosafety laboratory conditions, high technical demands on operators, and being time-consuming, making them less suitable for on-site analysis. The paper highlights the potential application of Surface Plasmon Resonance (SPR) biosensors in the detection of Coxiella burnetii. Researchers have developed an SPR-based biochip, which immobilizes a structural protein of Coxiella burnetii as the recognition molecule. By monitoring the binding reaction between specific anti-Coxiella burnetii antibodies and this protein, rapid quantitative detection is achieved. In summary, the paper aims to evaluate the role of biosensor technology in improving the speed and accuracy of Coxiella burnetii detection and to explore its potential position within existing standard diagnostic methods.